Status | Study |
Recruiting |
Study Name: Botulinum Toxin to Improve Lower Blepharoplasty Scar Condition: Other Degenerative Disorders of Eyelid and Periocular Area Date: 2016-05-26 Interventions: Drug: Botulinum Toxin A total |
Withdrawn |
Study Name: PMCF-study Using Novosyn® Quick Suture Material in Ophthalmic Surgery Condition: Dacryocystorhinostomy Ectropion Entropion Date: 2016-05-03 Interventions: Device: Novosyn® Quick Ey |
Not yet recruiting |
Study Name: Two Different Surgical Methods of Blepharospasm Condition: Blepharospasm Date: 2016-04-14 Interventions: Procedure: Facial nerve combing |
Not yet recruiting |
Study Name: Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair Condition: Blepharoptosis Date: 2015-07-12 Interventions: Procedure: Levator advancement |
Completed |
Study Name: Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis Condition: Acquired Blepharoptosis Date: 2015-05-04 Interventions: Drug: RVL-1201 RVL-1201 Ophtha |
Recruiting |
Study Name: rTMS and Botulinum Toxin in Benign Essential Blepharospasm Condition: Benign Essential Blepharospasm Date: 2015-02-10 Interventions: Device: Magstim RapidStim2 App |
Completed |
Study Name: Digital Photographs to Evaluate Blepharoptosis Condition: Blepharoptosis Date: 2015-02-03 Interventions: Other: Method comparison |
Completed |
Study Name: Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm Condition: Blepharospasm Date: 2014-12-18 Interventions: Procedure: Botulinum toxin A injection (5 sites: 12.5U) |
Completed |
Study Name: Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Condition: Chronic Blepharitis Date: 2014-09-08 Interventions: Drug: Ivermectin 0.1% Metronidazole 1% Other Name: 22,23-dihydroavermectin B1a + 22,23-dihydroavermectin |
Completed |
Study Name: Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Condition: Blepharitis Date: 2014-08-13 Interventions: Drug: KPI-121 KPI-121 drug pro |